These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 4889728)
21. Changes of general haemodynamics during stressful mental arithmetic and non-stressing quiet conversation and modification of the latter by beta-adrenergic blockade. Ulrych M Clin Sci; 1969 Jun; 36(3):453-61. PubMed ID: 5795235 [No Abstract] [Full Text] [Related]
22. Cardiovascular toxicity: clinical evaluation of albuterol, isoproterenol and placebo in rising dose tolerance trial. Finch JS Ann Allergy; 1981 Nov; 47(5 Pt 2):402-4. PubMed ID: 7030155 [No Abstract] [Full Text] [Related]
23. [Pharmacologic properties of 2 new derivatives of unsaturated amino alcohols]. Batrak GE; Malinovskiĭ MS; Khmel' MP Farmakol Toksikol; 1970; 33(2):202-3. PubMed ID: 5425627 [No Abstract] [Full Text] [Related]
24. [Labor inhibition with a new beta-adrenergic drug]. Boden W; von der Crabben H Med Welt; 1970 Jul; 30():1342-9. PubMed ID: 5508256 [No Abstract] [Full Text] [Related]
25. The effects of hexobendine on cerebral blood flow and metabolism. A contribution towards the understanding of the mechanism of action of cerebral vasodilatory drugs. Kraupp O; Nell G; Raberger G; Stühlinger W Arzneimittelforschung; 1969 Oct; 19(10):1691-8. PubMed ID: 5395369 [No Abstract] [Full Text] [Related]
26. [The effects of a beta-adrenergic blocking agent (INPEA) on systemic and coronary hemodynamics in the dog]. Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E Boll Soc Ital Biol Sper; 1967 Mar; 43(6):313-5. PubMed ID: 6056650 [No Abstract] [Full Text] [Related]
27. Pharmacological properties of 1-(4'-nitrophenyl)-2-isopropylamino-ethanol (INPEA), a new beta-adrenergic receptor antagonist. IV. Effects of the optical isomers D (minus) and L (plus) INPEA on the arterial pressure and on the pressor responses to noradrenaline, adrenaline and isoproterenol in urethan-anesthetised rats. Murmann W; Gamba A Boll Chim Farm; 1967 Feb; 106(2):101-8. PubMed ID: 5608202 [No Abstract] [Full Text] [Related]
28. [o-Allyloxy-phenoxy-propanolamine, a new group of adrenergic beta-receptor blocking agents]. Wilhelm M; Hedwall P; Meier M Experientia; 1967 Aug; 23(8):651-2. PubMed ID: 6051695 [No Abstract] [Full Text] [Related]
29. Initial studies on the human pharmacology of salbutamol. Simpson WT Postgrad Med J; 1971 Mar; 47():Suppl:35-8. PubMed ID: 5572513 [No Abstract] [Full Text] [Related]
30. Effect of a new adrenergic beta-blocking agent, H 56-28, on nervous heart complaints. Nordenfelt I; Persson S; Redfors A Acta Med Scand; 1968 Dec; 184(6):465-71. PubMed ID: 4885079 [No Abstract] [Full Text] [Related]
31. [The effect of norfenefrine on circulation, plasma catecholamines and metabolism at rest and during exertion]. Schmitt WM; Kindermann W; Stengele E; André W Z Kardiol; 1983 Jun; 72(6):321-6. PubMed ID: 6351455 [TBL] [Abstract][Full Text] [Related]
32. Inotropic and chronotropic effects of two stereoisomers of butidrine, a new adrenergic beta-blocking agent, on isolated rabbit heart and rat auricles. Bertaccini G; Impicciatore M; Visioli O; Malagnino G Farmaco Sci; 1968 Mar; 23(3):183-96. PubMed ID: 5713108 [No Abstract] [Full Text] [Related]
33. [Modification of the influence of non-specific brain system stimulation on muscular work capacity by beta-adrenergic receptor blockaders]. Kruk B Acta Physiol Pol; 1971; 22(4):475-82. PubMed ID: 4399008 [No Abstract] [Full Text] [Related]
34. [Experimental and clinical results of a new blood pressure increasing substance (2,5-dimethoxyphenyl-2-glycinamidoethanol-1-hydrochloride)]. Paumgartner G; Pokorny D; Grabner G Wien Klin Wochenschr; 1970 Jun; 82(26):490-4. PubMed ID: 5520165 [No Abstract] [Full Text] [Related]
35. [Glucose, catecholamines, pyruvic and lactic acid level in the vascular wall of the cat under the effect of nafarine and vicasol]. Smirnov PA Farmakol Toksikol; 1972; 35(3):291-4. PubMed ID: 5047291 [No Abstract] [Full Text] [Related]
36. Effect of respiratory acidosis on heart and circulation in cats, pigs, dogs and rabbits. Köhler E; Noack E; Strobach H; Wirth K Res Exp Med (Berl); 1972; 158(4):308-20. PubMed ID: 5085439 [No Abstract] [Full Text] [Related]
37. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients. Piva M; Ongari R Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376 [No Abstract] [Full Text] [Related]
38. [Preparation of heart and circulation effective compounds. 2]. Schulz H Pharmazie; 1968 May; 23(5):240-2. PubMed ID: 5717165 [No Abstract] [Full Text] [Related]
39. [Modification of the effect of insulin by DL-4 (2-hydroxy-3-isopropylaminopropoxy)-indole (Visken, LB 46) in normal and diabetic persons]. Lisch HJ; Sailer S; Sandhofer F; Braunsteiner H Schweiz Med Wochenschr; 1972 Apr; 102(14):510-4. PubMed ID: 5019768 [No Abstract] [Full Text] [Related]
40. [Effects of 1-4-dihydrazinophthalazine on arterial pressure and heart rate, before and after administration of beta-blocking drugs]. Campus S; Rappelli A; Fabris F; Mathis I Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1847-51. PubMed ID: 5602829 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]